Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

Cited by (1,005)

Items 201–300 of 1,005

1. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer’s disease is related to the apolipoprotein E genotype
   Charles Ramassamy, Diana A. Averill‐Bates, Uwe Beffert, Stéphane Bastianetto, Louise Théroux, Suzanne Lussier‐Cacan, Jeffrey S. Cohn, Yves Christen, Jean Davignon, Rémi Quirion et al. · 1999 · Free Radical Biology and Medicine
2. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer’s disease
   Urbanc, B., Cruz, L., Le, R., Sanders, J., Ashe, K. Hsiao, Duff, K., Stanley, H. E., Irizarry, M. C., Hyman, B. T. · 2002 · Proceedings of the National Academy of Sciences
3. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
   Colin Louis Masters, Roberto Cappai, Kevin Jeffrey Barnham, Victor L. Villemagne · 2006 · Journal of Neurochemistry
4. Non-A.beta. Component of Alzheimer's Disease Amyloid (NAC) is Amyloidogenic
   Akihiko Iwai, Makoto Yoshimoto, Eliezer Masliah, Tsunao Saitoh · 1995 · Biochemistry
5. Protein Ectodomain Shedding
   Joaquı́n Arribas, Aldo Borroto · 2002 · Chemical Reviews
6. The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease
   Hirsch-Reinshagen, Veronica, Maia, Luis F., Burgess, Braydon L., Blain, Jean-Francois, Naus, Kathryn E., McIsaac, Sean A., Parkinson, Pamela F., Chan, Jennifer Y., Tansley, Gavin H., Hayden, Michael R. et al. · 2005 · Journal of Biological Chemistry
7. Genetics of Alzheimer's Disease: A Centennial Review
   Nilüfer Ertekin‐Taner · 2007 · Neurologic Clinics
8. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides.
   Wertkin, A M, Turner, R S, Pleasure, S J, Golde, T E, Younkin, S G, Trojanowski, J Q, Lee, V M · 1993 · Proceedings of the National Academy of Sciences
9. Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
   Haythum Osama Tayeb, Hyun Duk Yang, Bruce Heimburger Price, Frank I. Tarazi · 2011 · Pharmacology & Therapeutics
10. Glaucoma ocular Alzheimer s disease
    Stuart J. McKinnon · 2003 · Frontiers in bioscience
11. Dual‐specificity tyrosine(Y)‐phosphorylation regulated kinase 1A‐mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s disease
    Soo‐Ryoon Ryoo, Hyunjeong Cho, Hye Won Lee, Hey Kyeong Jeong, Chinzorig Radnaabazar, Yeun‐Soo Kim, Minjeong Kim, Mi‐Young Son, Hyemyung Seo, Sul‐Hee Chung et al. · 2007 · Journal of Neurochemistry
12. Reactive oxygen species and Alzheimer's disease
    Gerd Multhaup, Thomas Ruppert, Andrea Schlicksupp, Lars Hesse, Dirk Beher, Colin Louis Masters, Konrad Beyreuther · 1997 · Biochemical Pharmacology
13. The Alzheimer’s Disease-Associated Presenilins Are Differentially Phosphorylated Proteins Located Predominantly within the Endoplasmic Reticulum
    Jochen Walter, Anja Capell, Jürgen Grünberg, Brigitte Pesold, Alice Schindzielorz, Reinhard Prior, Marcia Berman Podlisny, Paul Fraser, Peter St George‐Hyslop, Dennis J. Selkoe et al. · 1996 · Molecular Medicine
14. Constitutive secretion of tau protein by an unconventional mechanism
    Xiyun Chai, Jeffrey L. Dage, Martin Citron · 2012 · Neurobiology of Disease
15. Presenilin and nicastrin regulate each other and determine amyloid β-peptide production via complex formation
    Dieter Edbauer, Edith Winkler, Christian Haass, Harald Steiner · 2002 · Proceedings of the National Academy of Sciences
16. Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability
    De Jonghe, C. · 2001 · Human Molecular Genetics
17. Mechanisms of Neuroprotection by a Novel Rescue Factor Humanin from Swedish Mutant Amyloid Precursor Protein
    Yuichi Hashimoto, Yuko Ito, Takako Niikura, Zongjun Shao, Michihiro Hata, Fumitaka Oyama, Ikuo Nishimoto · 2001 · Biochemical and Biophysical Research Communications
18. Intracellular Mechanisms of Amyloid Accumulation and Pathogenesis in Alzheimer's Disease
    Glabe, Charles · 2001 · Journal of Molecular Neuroscience
19. Regulation of Amyloid Precursor Protein Cleavage
    Julia Mills, Peter B. Reiner · 1999 · Journal of Neurochemistry
20. NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque‐competence, Aβ(1–40)ox and Aβ(1–42)ox
    Roland Riek, Peter Güntert, Heinz Döbeli, Beat Wipf, Kurt Wüthrich · 2001 · European Journal of Biochemistry
21. Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
    Sahni, Jasjeet Kaur, Doggui, Sihem, Ali, Javed, Baboota, Sanjula, Dao, Lé, Ramassamy, Charles · 2011 · Journal of Controlled Release
22. Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion
    Nitsch, Roger M., Deng, Meihua, Growdon, John H., Wurtman, Richard J. · 1996 · Journal of Biological Chemistry
23. Oxidative stress potentiates BACE1 gene expression and A? generation
    Y. Tong, Weihui Zhou, Vincent Fung, Michelle A. Christensen, Hong Qing, Xiulian Sun, Weihong Song · 2004 · Journal of Neural Transmission
24. Amyloid β peptide induces necrosis rather than apoptosis
    Christian Behl, John B. Davis, F. George Klier, David Schubert · 1994 · Brain Research
25. Early-Onset Familial Alzheimer's Disease (EOFAD)
    Liyong Wu, Pedro Rosa‐Neto, Ging‐Yuek Robin Hsiung, Adele Dessa Sadovnick, Mario Masellis, Sandra E. Black, Jianping Jia, Serge G. Gauthier · 2012 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
26. Transcriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1
    Michelle A. Christensen, Weihui Zhou, Hong Qing, Anna Lehman, Sjaak Philipsen, Weihong Song · 2003 · Molecular and Cellular Biology
27. Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease
    Shiyong Peng, Diego J. Garzon, Monica Marchese, William L. Klein, Stephen D. Ginsberg, Beverly M. Francis, Howard T.J. Mount, Elliott Jay Mufson, Ahmad Salehi, Margaret L. Fahnestock · 2009 · Journal of Neuroscience
28. Homodimerization of Amyloid Precursor Protein and Its Implication in the Amyloidogenic Pathway of Alzheimer's Disease
    Stefan Scheuermann, Boris Hambsch, Lars Hesse, Joachim Stumm, Carsten Schmidt, Dirk Beher, Thomas A. Bayer, Konrad T. Beyreuther, Gerd Multhaup · 2001 · Journal of Biological Chemistry
29. The role of APP and BACE1 trafficking in APP processing and amyloid-β generation
    Xiaojie Zhang, Weihong Song · 2013 · Alzheimer s Research & Therapy
30. Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines
    Daniela Puzzo, Linda S. Lee, Agostino Palmeri, Giorgio Calabrese, Ottavio Arancio · 2014 · Biochemical Pharmacology
31. Insulin-degrading Enzyme Rapidly Removes the β-Amyloid Precursor Protein Intracellular Domain (AICD)
    Dieter Edbauer, Michael Willem, Sven Lammich, Harald Steiner, Christian Haass · 2002 · Journal of Biological Chemistry
32. A Substrate-Based Difluoro Ketone Selectively Inhibits Alzheimer's γ-Secretase Activity
    Michael S. Wolfe, Martin Citron, Thekla S. Diehl, Weiming Xia, Isaac O. Donkor, Dennis J. Selkoe · 1998 · Journal of Medicinal Chemistry
33. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level
    Sadleir, Katherine R, Eimer, William A, Cole, Sarah L, Vassar, Robert · 2015 · Molecular Neurodegeneration
34. Turnover of Amyloid β-Protein in Mouse Brain and Acute Reduction of Its Level by Phorbol Ester
    Savage, Mary J., Trusko, Stephen P., Howland, David S., Pinsker, Leonard R., Mistretta, Suzanne, Reaume, Andrew G., Greenberg, Barry D., Siman, Robert, Scott, Richard W. · 1998 · The Journal of Neuroscience
35. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).
    Hyman, B T, West, H L, Rebeck, G W, Buldyrev, S V, Mantegna, R N, Ukleja, M, Havlin, S, Stanley, H E · 1995 · Proceedings of the National Academy of Sciences
36. Proapoptotic Effects of Tau Cleavage Product Generated by Caspase-3
    Chul-Woong Chung, Yu-Hyun Song, In-Ki Kim, Won Joo Yoon, Bo Rum Ryu, Dong‐Gyu Jo, Ha‐Na Woo, Yun-Kyong Kwon, Hyun‐Hee Kim, Byoung-Joo Gwag et al. · 2001 · Neurobiology of Disease
37. Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein
    Andreas Weidemann, Krzysztof Paliga, Ulrike Dürrwang, Christian Czech, Genevieve M. Evin, Colin Louis Masters, Konrad T. Beyreuther · 1997 · Nature Medicine
38. Flotillin-Dependent Clustering of the Amyloid Precursor Protein Regulates Its Endocytosis and Amyloidogenic Processing in Neurons
    Anja Schneider, Lawrence Rajendran, Masanori Honsho, Matthias Gralle, Gerald Donnert, Fred Silvester Wouters, Stefan W. Hell, Mikael Simons · 2008 · Journal of Neuroscience
39. The Transcriptionally Active Amyloid Precursor Protein (APP) Intracellular Domain Is Preferentially Produced from the 695 Isoform of APP in a β-Secretase-dependent Pathway
    Nikolai D. Belyaev, Katherine A. B. Kellett, Caroline Beckett, Natalia Z. Makova, Timothy J. Revett, Natalia N. Nalivaeva, Nigel M. Hooper, Anthony J. Turner · 2010 · Journal of Biological Chemistry
40. Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein
    Stephen M. Fitzjohn, Robin A. Morton, Frederick M. Kuenzi, Thomas W. Rosahl, Mark S. Shearman, Huw D. Lewis, David Smith, David S. Reynolds, Ceri H. Davies, Graham L. Collingridge et al. · 2001 · Journal of Neuroscience
41. Inhibitors of Cathepsin B Improve Memory and Reduce β-Amyloid in Transgenic Alzheimer Disease Mice Expressing the Wild-type, but Not the Swedish Mutant, β-Secretase Site of the Amyloid Precursor Protein
    VIVIAN Y. H. HOOK, Mark S. Kindy, Gregory Hook · 2008 · Journal of Biological Chemistry
42. Molecular genetics of Alzheimer's disease: An update
    Nathalie Brouwers, Kristel Sleegers, Christine Van Broeckhoven · 2008 · Annals of Medicine
43. The Toxicity of the Alzheimer's β-Amyloid Peptide Correlates with a Distinct Fiber Morphology
    Bernd Seilheimer, Bernd Bohrmann, Luca Bondolfi, Francis Müller, Dietrich Stüber, Heinz Döbeli · 1997 · Journal of Structural Biology
44. Full genome screen for Alzheimer disease: Stage II analysis*
    Amanda Myers, Fabienne Wavrant DeVriéze, Peter Holmans, Marian L. Hamshere, Richard Crook, Danielle Compton, Helen N. Marshall, David Meyer, Shantia Shears, Jeremy Booth et al. · 2002 · American Journal of Medical Genetics
45. Amyloid β Protein Starting Pyroglutamate at Position 3 Is a Major Component of the Amyloid Deposits in the Alzheimer's Disease Brain
    Harigaya, Yasuo, Saido, Takaomi C., Eckman, Christopher B., Prada, Cristian-Mihail, Shoji, Mikio, Younkin, Steven G. · 2000 · Biochemical and Biophysical Research Communications
46. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites.
    David G. Cook, J C Sung, Todd Eliot Golde, Kevin M. Felsenstein, Bogusław S. Wójczyk, Rudolph E. Tanzi, John Q. Trojanowski, V M Lee, Robert W. Doms · 1996 · Proceedings of the National Academy of Sciences
47. The X11α protein slows cellular amyloid precursor protein processing and reduces Aβ40 and Aβ42 secretion
    Borg, Jean-Paul, Yang, Yunning, De Taddéo-Borg, Mylène, Margolis, Ben, Turner, R. Scott · 1998 · Journal of Biological Chemistry
48. Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase
    Virginie Buggia-Prévot, Celia Fernandez, Sean M. Riordan, Kulandaivelu S. Vetrivel, Jelita Roseman, Jack Waters, Vytautas P. Bindokas, Robert J. Vassar, Gopal Thinakaran · 2014 · Molecular Neurodegeneration
49. Amyloid-β and Tau at the Crossroads of Alzheimer’s Disease
    Gilbert Gallardo, David M. Holtzman · 2019 · Advances in experimental medicine and biology
50. Expression in brain of amyloid precursor protein mutated in the alpha‐secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice.
    Moechars, D., Lorent, K., De Strooper, B., Dewachter, I., Van Leuven, F. · 1996 · The EMBO Journal
51. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis
    Jeffrey M. Redwine, Barry E. Kosofsky, Russell E. Jacobs, Dora Games, John F. Reilly, John H. Morrison, Warren G. Young, Floyd E. Bloom · 2003 · Proceedings of the National Academy of Sciences
52. Alzheimer Disease
    Mark A. Smith · 1998 · International review of neurobiology
53. The β-Secretase-Derived C-Terminal Fragment of βAPP, C99, But Not Aβ, Is a Key Contributor to Early Intraneuronal Lesions in Triple-Transgenic Mouse Hippocampus
    Lauritzen, Inger, Pardossi-Piquard, Raphaëlle, Bauer, Charlotte, Brigham, Elizabeth, Abraham, Jean-Daniel, Ranaldi, Sébastien, Fraser, Paul, St-George-Hyslop, Peter, Le Thuc, Ophelia, Espin, Vanessa et al. · 2012 · The Journal of Neuroscience
54. Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
    Janice A. Maloney, Travis W. Bainbridge, Amy E. Gustafson, Shuo Zhang, Roxanne V. Kyauk, Pascal Steiner, Marcel van der Brug, Yichin Liu, James A. Ernst, Ryan J. Watts et al. · 2014 · Journal of Biological Chemistry
55. Emerging roles of pathogens in Alzheimer disease
    Judith Miklossy · 2011 · Expert Reviews in Molecular Medicine
56. Cerebral Microvascular Amyloid β Protein Deposition Induces Vascular Degeneration and Neuroinflammation in Transgenic Mice Expressing Human Vasculotropic Mutant Amyloid β Precursor Protein
    Jianting Miao, Feng Xu, Judianne Davis, Irene Otte‐Höller, Marcel M. Verbeek, William E. Van Nostrand · 2005 · American Journal Of Pathology
57. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes
    Wong, Tak Pan, Debeir, Thomas, Duff, Karen, Cuello, A. Claudio · 1999 · The Journal of Neuroscience
58. Transcriptional and translational regulation of BACE1 expression—Implications for Alzheimer's disease
    Steffen Roßner, Magdalena Sastre, Krystyn Z. Bourne, Stefan F. Lichtenthaler · 2006 · Progress in Neurobiology
59. Characterization of Sorting Signals in the β-Amyloid Precursor Protein Cytoplasmic Domain
    Albert Lai, Sangram S. Sisodia, Ian S. Trowbridge · 1995 · Journal of Biological Chemistry
60. Expression of Alzheimer’s Disease-associated Presenilin-1 Is Controlled by Proteolytic Degradation and Complex Formation
    Harald Steiner, Anja Capell, Brigitte Pesold, Martin Citron, Peter Michael Kloetzel, Dennis J. Selkoe, Helmut Romig, Klaus D. Mendla, Christian Haass · 1998 · Journal of Biological Chemistry
61. Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease
    Weggen, Sascha, Beher, Dirk · 2012 · Alzheimer's Research & Therapy
62. Gleevec inhibits β-amyloid production but not Notch cleavage
    William J. Netzer, Fei Dou, Dongming Cai, Darren R. Veach, Stéphanie Jean, Yue‐Ming Li, William G. Bornmann, Bayard Clarkson, Huaxi Xu, Paul Greengard · 2003 · Proceedings of the National Academy of Sciences
63. Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts
    Matthias Gralle, Sergio Teixeira Ferreira · 2007 · Progress in Neurobiology
64. Animal models of Alzheimer's disease and evaluation of anti-dementia drugs
    Kiyofumi Yamada, Toshitaka Nabeshima · 2000 · Pharmacology & Therapeutics
65. Three Dimensional Human Neuro-Spheroid Model of Alzheimer’s Disease Based on Differentiated Induced Pluripotent Stem Cells
    Lee, Han-Kyu, Velazquez Sanchez, Clara, Chen, Mei, Morin, Peter J., Wells, John M., Hanlon, Eugene B., Xia, Weiming · 2016 · PLOS ONE
66. Muscarinic Regulation of Alzheimer's Disease Amyloid Precursor Protein Secretion and Amyloid β-Protein Production in Human Neuronal NT2N Cells
    Bryan A. Wolf, Andrew M. Wertkin, Y. Camille Jolly, Robert P. Yasuda, Barry B. Wolfe, Robert J. Konrad, David R. Manning, Sanjiv Ravi, JOHN R. WILLIAMSON, Virginia M.‐Y. Lee · 1995 · Journal of Biological Chemistry
67. Structural basis of γ-secretase inhibition and modulation by small molecule drugs
    Yang, Guanghui, Zhou, Rui, Guo, Xuefei, Yan, Chuangye, Lei, Jianlin, Shi, Yigong · 2021 · Cell
68. Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis
    Roberta Cascella, Cristina Cecchi · 2021 · International Journal of Molecular Sciences
69. Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease
    Lydia Reznichenko, Tamar Amit, Hailin Zheng, Yael Avramovich‐Tirosh, Moussa B. H. Youdim, Orly Weinreb, Silvia A. Mandel · 2006 · Journal of Neurochemistry
70. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium
    Mark P. Mattson, Yadong Goodman · 1995 · Brain Research
71. Increased β-secretase activity and expression in rats following transient cerebral ischemia
    Yi Wen, Otuonye Onyewuchi, Shao‐Hua Yang, Ran Liu, James W. Simpkins · 2004 · Brain Research
72. β-Amyloid accumulation in aged canine brain: A model of early plaque formation in Alzheimer's disease
    Brian J Cummings, Joseph H. Su, Carl W. Cotman, R. G. White, Michael J. Russell · 1993 · Neurobiology of Aging
73. Presenilin-1 affects trafficking and processing of βAPP and is targeted in a complex with nicastrin to the plasma membrane
    Christoph Kaether, Sven Lammich, Dieter Edbauer, Michaela Ertl, Jens Rietdorf, Anja Capell, Harald Steiner, Christian Haass · 2002 · The Journal of Cell Biology
74. p53-Dependent Cell Death Signaling in Neurons
    Richard S. Morrison, Yoshito Kinoshita, Mark D. Johnson, Weiqun Guo, Gwenn A. Garden · 2003 · Neurochemical Research
75. Biology of Aβ Amyloid in Alzheimer's Disease
    Thomas Wısnıewskı, Jorge A. Ghiso, Blas Frangione · 1997 · Neurobiology of Disease
76. Neuronal Cell Death in Alzheimers Disease and a Neuroprotective Factor, Humanin
    Niikura, Takako, Tajima, Hirohisa, Kita, Yoshiko · 2006 · Current Neuropharmacology
77. Degradation of Alzheimer's ß-Amyloid Protein by Human and Rat Brain Peptidases: Involvement of Insulin-Degrading Enzyme
    JOHN R. MCDERMOTT, ALISON M. GIBSON · 1997 · Neurochemical Research
78. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
    David M. A. Mann, Takeshi Iwatsubo, Yasuo Ihara, Nigel J. Cairns, Peter L Lantos, Nenad Bogdanović, Lars Lannfelt, Bengt G. Winblad, Marion L. C. Maat–Schieman, Martin N. Rossor · 1996 · Europe PMC (PubMed Central)
79. Amyloid assembly and disassembly
    Edward Chuang, Acacia M Hori, Christina D. Hesketh, James Shorter · 2018 · Journal of Cell Science
80. Phosphorylation of amyloid beta (Aβ) peptides – A trigger for formation of toxic aggregates in Alzheimer's disease
    Sathish Kumar, Jochen Walter · 2011 · Aging
81. Genetics and molecular advances in Alzheimer's disease
    Mike Mullan, Fiona Crawford · 1993 · Trends in Neurosciences
82. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer’s disease
    Liu, Chia-Chen, Zhao, Na, Yamaguchi, Yu, Cirrito, John R., Kanekiyo, Takahisa, Holtzman, David M., Bu, Guojun · 2016 · Science Translational Medicine
83. Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 Transgenes
    Eileen M. McGowan, Sunny Sanders, Takeshi Iwatsubo, A. Takeuchi, Takaomi C. Saido, Cindy Zehr, Xin Yu, Sacha Uljon, R. Wang, David M. A. Mann et al. · 1999 · Neurobiology of Disease
84. Gene structure and organization of the human β‐secretase ( BACE ) promoter
    Kumar Sambamurti, Rachel Kinsey, Bryan Maloney, Yuan‐Wen Ge, Debomoy K. Lahiri · 2004 · The FASEB Journal
85. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors.
    R K Lee, Richard Jay Wurtman, A J Cox, Roger M. Nitsch · 1995 · Proceedings of the National Academy of Sciences
86. Unusual phenotypic alteration of β amyloid precursor protein (βAPP) maturation by a new Val-715 → Met βAPP-770 mutation responsible for probable early-onset Alzheimer’s disease
    Karine Ancolio, Cécile Dumanchin‐Njock, Hélène Barelli, Jean‐Marie Warter, Alexis Brice, Dominique Campion, Thierry Frébourg, Frédéric Checler · 1999 · Proceedings of the National Academy of Sciences
87. The Chaperone BiP/GRP78 Binds to Amyloid Precursor Protein and Decreases Aβ40 and Aβ42 Secretion
    Yunning Yang, Raymond Scott Turner, James R. Gaut · 1998 · Journal of Biological Chemistry
88. Aβ Toxicity in Alzheimer's Disease
    Virve Cavallucci, Marcello D’Amelio, Francesco Cecconi · 2012 · Molecular Neurobiology
89. Genetic dissection of Alzheimer disease, a heterogeneous disorder.
    Gerard D. Schellenberg · 1995 · Proceedings of the National Academy of Sciences
90. Production of intracellular amyloid‐containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence.
    Bart De Strooper, Mikael Simons, Gerd Multhaup, Fred VAN LEUVEN, Konrad T. Beyreuther, Carlos G. Dotti · 1995 · The EMBO Journal
91. Proteoglycan-mediated Inhibition of Aβ Proteolysis
    Rekha Gupta‐Bansal, Robert C.A. Frederickson, Kurt R. Brunden · 1995 · Journal of Biological Chemistry
92. Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism
    David Allan Butterfield, Miranda L. Bader Lange · 2009 · Journal of Neurochemistry
93. Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation
    Celio A. Marques, Uta Keil, Astrid Bonert, Barbara Steiner, Christian Haass, Walter E. Müller, Anne Eckert · 2003 · Journal of Biological Chemistry
94. Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's diseas
    Lars Lannfelt, Hans Basun, Lars‐Olof Wahlund, Blake A. Rowe, Steven L. Wagner · 1995 · Nature Medicine
95. Identification of Distinct γ-Secretase Complexes with Different APH-1 Variants
    Keiro Shirotani, Dieter Edbauer, Stefan Prokop, Christian Haass, Harald Steiner · 2004 · Journal of Biological Chemistry
96. Proteolytic Processing of the Alzheimer's Disease Amyloid Precursor Protein within Its Cytoplasmic Domain by Caspase-like Proteases
    Andreas Weidemann, Krzysztof Paliga, Ulrike Dürrwang, Friedrich B. M. Reinhard, Oliver Schuckert, Genevieve M. Evin, Colin Louis Masters · 1999 · Journal of Biological Chemistry
97. The role of p53 in neuronal cell death
    Richard S. Morrison, Y Kinoshita · 2000 · Cell Death and Differentiation
98. Sphingolipids: Critical players in Alzheimer’s disease
    Gerhild van Echten‐Deckert, Jochen Walter · 2012 · Progress in Lipid Research
99. γ-secretases: from cell biology to therapeutic strategies
    Bruno A. Bergmans, Bart De Strooper · 2010 · The Lancet Neurology
100. Key Factors in Alzheimer's Disease: β‐amyloid Precursor Protein Processing, Metabolism and Intraneuronal Transport
     Thomas A. Bayer, Oliver Wirths, Katalin Majtényi, Tobias Hartmann, Gerd Multhaup, Konrad T. Beyreuther, Christian Czech · 2001 · Brain Pathology